nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

01.08.2016 | Autonomic Dysfunction (LH Weimer, Section Editor)

Pure Autonomic Failure

verfasst von: Pariwat Thaisetthawatkul

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Pure autonomic failure (PAF) is a rare sporadic neurodegenerative autonomic disorder characterized by slowly progressive pan autonomic failure without other features of neurologic dysfunctions. The main clinical symptoms result from neurogenic orthostatic hypotension and urinary and gastrointestinal autonomic dysfunctions. Autonomic failure in PAF is caused by neuronal degeneration of pre- and postganglionic sympathetic and parasympathetic neurons in the thoracic spinal cord and paravertebral autonomic ganglia. The presence of Lewy bodies and α-synuclein deposits in these neural structures suggests that PAF is one of Lewy body synucleinopathies, examples of which include multiple system atrophy, Parkinson disease, and Lewy body disease. There is currently no specific treatment to stop progression in PAF. Management of autonomic symptoms is the mainstay of treatment and includes management of orthostatic hypotension and supine hypertension. The prognosis for survival of PAF is better than for the other synucleinopathies.

Bradbury S, Eggleston C. Postural hypotension: a report of three cases. Am Heart J. 1925;1:73–86.CrossRef

Garland E, Hooper W, Robertson D. Pure autonomic failure. Handb Clin Neurol. 2013;117:243–7.CrossRefPubMed

Oppenheimer DR. Lateral horn cells in progressive autonomic failure. J Neurol Sci. 1980;46:393–404.CrossRefPubMed

Matthews MR. Assessing the peripheral ganglia in autonomic failure. In: Bannister R, editor. Autonomic Failure. A textbook of clinical disorders of the autonomic nervous system. 2nd ed. Oxford: Oxford University Press; 1988. p. 511–43.

Goldstein DS, Polinsky RJ, Gatty M, Robertson D, Brown RT, Biaggioni I, et al. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol. 1989;26:558–63.CrossRefPubMed

Van Ingelghem E, van Zandijcke M, Lammens M. Pure autonomic failure: a new case with clinical, biochemical, and necropsy data. J Neurol Neurosurg Psychiatry. 1994;57:745–7.CrossRefPubMedPubMedCentral

Hague K, Lento P, Morgello S, Caro S, Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol. 1997;94:192–6.CrossRefPubMed

Arai K, Kato N, Kashiwado K, Hattori T. Pure autonomic failure in association with human a-synucleinopathy. Neurosci Lett. 2000;296:171–3.CrossRefPubMed

Kaufmann H, Hague K, Perl D. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurology. 2001;56:980–1.CrossRefPubMed

10.

Mathias C, Mallipeddi R, Bleasdale-Barr K. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. J Neurol. 1999;246:893–8.CrossRefPubMed

11.

Bleadales-Barr K, Mathias C. Neck and other muscle pains in autonomic failure: their association of orthostatic hypotension. J R Soc Med. 1998;91:355–9.

12.

Smith GDP, Mathias C. Postural hypotension enhanced by exercise in patients with chronic autonomic failure. Q J Med. 1995;88:251–6.

13.

Mathias CJ, Holly E, Armstrong E, Shareef M, Bannister R. The influence of food on postural hypotension in three groups with chronic autonomic failure clinical and therapeutic implications. J Neurol Neurosurg Psychiatry. 1991;54:726–30.CrossRefPubMedPubMedCentral

14.

Caronna JJ, Plum F. Cerebrovascular regulation in preganglionic and postganglionic autonomic insufficiency. Stroke. 1973;4:12–9.CrossRefPubMed

15.

Brooks DJ, Redmond S, Mathias CJ, Bannister R, Symon L. The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine. J Neurol Neurosurg Psychiatry. 1989;52:962–6.CrossRefPubMedPubMedCentral

16.

Gurevich T, Gur AY, Bornstein NM, Giladi N, Korczyn AD. Cerebral vasomotor reactivity in Parkinson's disease, multiple system atrophy and pure autonomic failure. J Neurol Sci. 2006;243:57–60.CrossRefPubMed

17.

Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension. 1997;30:1062–7.CrossRefPubMed

18.

Vagaonescu TD, Saadia D, Turhim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patient with primary autonomic failure. Lancet. 2000;355:725–6.CrossRefPubMed

19.

Garland E, Gamboa A, Okamato L, Raj S, Black B, Davis T, et al. The renal impairment of pure autonomic failure. Hypertension. 2009;54:1057–61.CrossRefPubMedPubMedCentral

20.

Struhal W, Lahrmann H, Mathias C. Incidence of cerebrovascular lesions in pure autonomic failure. Incidence of cerebrovascular lesions in pure autonomic failure. Auton Neurosci. 2013;179:159–62.CrossRefPubMed

21.

Shannon J, Jordan J, Diedrich A, Pohar B, Black B, Robertson D, et al. Sympathetically mediated hypertension in autonomic failure. Circulation. 2000;101:2710–5.CrossRefPubMed

22.

Sakakibara R, Hattori T, Uchiyama T, Asahina M, Yamanishi T. Micturitional disturbance in pure autonomic failure. Neurology. 2000;54:499–501.CrossRefPubMed

23.

Yamanaka Y, Sakakibara R, Asahina M, Uchiyama T, Liu Z, Yamamoto T, et al. Chronic intestinal pseudo-obstruction as the initial feature of pure autonomic failure. J Neurol Neurosurg Psychiatry. 2006;77:800.CrossRefPubMedPubMedCentral

24.

Idiaquez J, Fadic R, Verdugo R, Idiaquez JF, Iodice V, Low DA, et al. Pure autonomic failure with cold induced sweating. Auton Neurosci. 2013;176:98–100.CrossRefPubMed

25.

Weyer A, Minnerop M, Abele M, Klockgether T. REM sleep behavioral disorder in pure autonomic failure (PAF). Neurology. 2006;66:608–9.CrossRefPubMed

26.

Bremner F, Smith S. Pupil findings in a consecutive series of 150 patients with generalised autonomic neuropathy. J Neurol Neurosurg Psychiatry. 2006;77:1163–8.CrossRefPubMedPubMedCentral

27.

Silveira-Moriyama L, Mathias C, Mason L, Best C, Quinn NP, Lees AJ. Hyposmia in pure autonomic failure. Neurology. 2009;72:1677–81.CrossRefPubMed

28.

Goldstein DS, Sewell L. Olfactory dysfunction in pure autonomic failure: implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord. 2009;15:516–20.CrossRefPubMedPubMedCentral

29.

Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318:121–34.CrossRefPubMed

30.

Heims HC, Critchley HD, Martin NH, Jäger HR, Mathias CJ, Cipolotti L. Cognitive functioning in orthostatic hypotension due to pure autonomic failure. Clin Auton Res. 2006;16:113–20.CrossRefPubMed

31.

Johnson RH, Lee Gde J, Oppenheimer DR, Spalding JM. Autonomic failure with orthostatic hypotension due to intermediolateral column degeneration. A report of two cases with autopsies. Q J Med. 1966;35:276–92.PubMed

32.

Bannister R, Crowe R, Eames R, Burnstock G. Adrenergic innervation in autonomic failure. Neurology. 1981;31:1501–6.CrossRefPubMed

33.

Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A. 1998;95:6469–73.CrossRefPubMedPubMedCentral

34.

Kaufmann H, Goldstein DS. Pure autonomic failure: a restricted Lewy body synucleinopathy or early Parkinson disease? Neurology. 2010;74:536–7.CrossRefPubMed

35.•

Donadio V, Incensi A, Cortelli P, Giannoccaro MP, Jaber MA, Baruzzi A, et al. Skin sympathetic fiber α-synuclein deposits: a potential biomarker for pure autonomic failure. Neurology. 2013;80:725–32. Donadio et al demonstrated phosphorylated a-synuclein in the skin sympathetic nerves and suggested that a-synuclein could be in vivo biomarker for PAF.CrossRefPubMed

36.

Wang N, Gibbons CH, Lafo J, Freeman R. α-Synuclein in cutaneous autonomic nerves. Neurology. 2013;81:1604–10.CrossRefPubMedPubMedCentral

37.

Donadio V, Incensi A, Piccinini C, Cortelli P, Giannoccaro MP, Baruzzi A, et al. Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease. Ann Neurol. 2016;79:306–16.CrossRefPubMed

38.

Masuda H, Asahina M, Oide T, Wakita H, Sekiguchi Y, Araki N, et al. Antemortem detection of colonic α-synuclein pathology in a patient with pure autonomic failure. J Neurol. 2014;261:2451–2.CrossRefPubMed

39.

Kanda T, Tomimitsu H, Yokota T, Ohkoshi N, Hayashi M, Mizusawa H. Unmyelinated nerve fibers in sural nerve in pure autonomic failure. Ann Neurol. 1998;43:267–71.CrossRefPubMed

40.

Donadio V, Cortelli P, Elam M, Di Stasi V, Montagna P, Holmberg B, et al. Autonomic innervation in multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry. 2010;81:1327–35.CrossRefPubMed

41.

Low PA, Sletten DM. Laboratory evaluation of autonomic failure. In: Low PA, Benarroch EE, editors. Clinical autonomic disorders. 3rd ed. Baltimore: Lippincott Williams; 2008. p. 130–63.

42.

Cohen J, Low P, Fealey R, Sheps S, Jiang NS. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol. 1987;22:692–9.CrossRefPubMed

43.

Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD. Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension. 1992;19:628–33.CrossRefPubMed

44.

Meredith IT, Esler MD, Cox HS, Lambert GW, Jennings GL, Eisenhofer G. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Auton Res. 1991;1:187–94.CrossRefPubMed

45.

Goldstein DS. Imaging studies in chronic autonomic disorders. In: Low PA, Benarroch EE, editors. Clinical autonomic disorders. 3rd ed. Baltimore: Lippincott Williams & Wilkins; 2008. p. 336–44.

46.

Yoshida M, Fukumoto Y, Kuroda Y, Ohkoshi N. Sympathetic denervation of myocardium demonstrated by 123I-MIBG scintigraphy in pure progressive autonomic failure. Eur Neurol. 1997;38:291–6.CrossRefPubMed

47.

Tipre DN, Goldstein DS. Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med. 2005;46:1775–81.PubMed

48.

Braune S, Reinhardt M, Bathmann J, Krause T, Lehmann M, Lücking CH. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand. 1998;97:307–14.CrossRefPubMed

49.

Druschky A, Hilz MJ, Platsch G, Radespiel-Tröger M, Druschky K, Kuwert T, et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci. 2000;175:3–12.CrossRefPubMed

50.

Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K, et al. Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2002;73:776–7.CrossRefPubMedPubMedCentral

51.•

Peeraully T. Multiple system atrophy. Semin Neurol. 2014;34:174–81. An in-depth updated review on MSA.CrossRefPubMed

52.

Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr MD. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology. 1992;42:590–3.CrossRefPubMed

53.•

Schroeder C, Jordan J, Kaufmann H. Management of neurogenic orthostatic hypotension in patients with autonomic failure. Drugs. 2013;73:1267–79. A very comprehensive review of management of neurogenic orthostatic hypotension.CrossRefPubMed

54.•

Low PA. Neurogenic orthostatic hypotension: pathophysiology and diagnosis. Am J Manag Care. 2015;21:s248–57. A very updated review on pathophysiology of neurogenic orthostatic hypotension.PubMed

55.

Figueroa JJ, Singer W, Sandroni P, Sletten DM, Gehrking TL, Gehrking JA, et al. Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults with orthostatic hypotension. Arch Phys Med Rehabil. 2015;96:505–10.CrossRefPubMed

56.

Low PA, Fealey RD. Management of neurogenic orthostatic hypotension. In: Low PA, Benarroch EE, editors. Clinical autonomic disorders. 3rd ed. Baltimore: Lippincott Williams & Wilkins; 2008. p. 547–59.

57.

Cruz DN. Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension. Expert Opin Pharmacother. 2000;1:835–40.CrossRefPubMed

58.

Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993;95:38–48.CrossRefPubMed

59.

Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA. 1997;277:1046–51.CrossRefPubMed

60.

Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51:120–4.CrossRefPubMed

61.

Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74:1294–8.CrossRefPubMedPubMedCentral

62.

Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63:513–8.CrossRefPubMed

63.

Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med. 1979;301:68–73.CrossRefPubMed

64.••

Loavenbruck A, Sandroni P. Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions. Curr Med Res Opin. 2015;31:2095–104. Most updated and comprehensive on pathophysiology and management of neurogenic orthostatic hypotension.CrossRefPubMed

65.

Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, et al. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation. 2003;108:724–8.CrossRefPubMed

66.

Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83:328–35.CrossRefPubMedPubMedCentral

67.

Childress AC, Berry SA. Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents. Drugs. 2012;72:309–25.CrossRefPubMed

68.

Shibao C, Raj SR, Gamboa A, Diedrich A, Choi L, Black BK, et al. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension. 2007;50:47–53.CrossRefPubMed

69.

Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res. 1995;5:211–3.CrossRefPubMed

70.

Winkler AS, Landau S, Watkins PJ. Erythropoietin treatment of postural hypotension in anemic type 1 diabetic patients with autonomic neuropathy: a case study of four patients. Diabetes Care. 2001;24:1121–3.CrossRefPubMed

71.

Trahair LG, Horowitz M, Jones KL. Postprandial hypotension: a systematic review. J Am Med Dir Assoc. 2014;15:394–409.CrossRefPubMed

72.

Ong AC, Myint PK, Potter JF. Pharmacological treatment of postprandial reductions in blood pressure: a systematic review. J Am Geriatr Soc. 2014;62:649–61.CrossRefPubMed

73.

Fanciulli A, Strano S, Colosimo C, Caltagirone C, Spalletta G, Pontieri FE. The potential prognostic role of cardiovascular autonomic failure in α-synucleinopathies. Eur J Neurol. 2013;20:231–5.CrossRefPubMed

74.•

Goldstein DS, Holmes C, Sharabi Y, Wu T. Survival in synucleinopathies: a prospective cohort study. Neurology. 2015;85:1554–61. A new prospective study on survival analysis of many types of synucleinopathies.CrossRefPubMed

75.

Maule S, Milazzo V, Maule MM, Di Stefano C, Milan A, Veglio F. Mortality and prognosis in patients with neurogenic orthostatic hypotension. Funct Neurol. 2012;27:101–6.PubMedPubMedCentral

Titel: Pure Autonomic Failure
verfasst von: Pariwat Thaisetthawatkul
Publikationsdatum: 01.08.2016
Verlag: Springer US
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 8/2016
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-016-0673-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Pure Autonomic Failure

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

A Cognitive Overview of Limb Apraxia

The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs

The Utility of Cerebral Blood Flow Assessment in TBI

Alien Hand Syndrome

Isolated Abducens Nerve Palsy: Update on Evaluation and Diagnosis

Neuropsychological Effects of Cerebral Amyloid Angiopathy

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie